[冠状动脉内注射SIN-1及静脉注射吗多明后的冠状动脉扩张] - Suppr | 超能文献

[Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].

作者信息

Hug J, Hasenfuss G, Wollschläger H, Just H J, Bonzel T

机构信息

Abteilung Innere Medizin III, Kardiologie, Medizinische Universitätklinik Freiburg.

出版信息

Med Klin (Munich). 1994 Jul;89 Suppl 2:34-7.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Coronary dilatation after intracoronary administration of SIN-1 and intravenous molsidomine administration].[冠状动脉内注射SIN-1及静脉注射吗多明后的冠状动脉扩张]

Med Klin (Munich). 1994 Jul;89 Suppl 2:34-7.

2

[Effects of intravenous administration of nitroglycerin and SIN-1 or molsidomine on epicardial arterial diameter in patients with stable coronary heart disease].[静脉注射硝酸甘油、SIN-1或吗多明对稳定型冠心病患者心外膜动脉直径的影响]

Med Klin (Munich). 1994 Jul;89 Suppl 2:38-41.

3

[Diameter changes of epicardial coronary arteries and coronary stenoses after intracoronary application of SIN 1, a molsidomine metabolite].[应用硝普钠代谢物SIN 1冠脉内给药后心外膜冠状动脉直径变化及冠状动脉狭窄情况]

Z Kardiol. 1983 Jul;72(7):404-9.

4

[Influence of combination therapy (isosorbide dinitrate and molsidomine) on the incidence of angina pectoris in patients with coronary heart disease].[联合治疗（硝酸异山梨酯与吗多明）对冠心病患者心绞痛发生率的影响]

Praxis (Bern 1994). 1997 Nov 19;86(47):1849-53.

5

Coronary vasodilation with nitrocompounds--is there a maximum?硝基化合物引起的冠状动脉扩张——存在最大值吗？

Z Kardiol. 1989;78 Suppl 2:38-40; discussion 64-7.

6

[Acute and chronic effects of molsidomine in therapeutic coronary angioplasty].[吗多明在治疗性冠状动脉血管成形术中的急性和慢性作用]

Med Klin (Munich). 1990 Feb;85 Suppl 1:23-6.

7

Pharmacokinetics of linsidomine (SIN 1) after single and multiple intravenous short infusions in patients with renal insufficiency.肾功不全患者单次及多次静脉短时间输注后林西多明（SIN 1）的药代动力学

Int J Clin Pharmacol Ther Toxicol. 1993 Nov;31(11):533-41.

8

[New drug forms of molsidomine, Corvaton-forte and Corvaton-retard, and their antianginal efficacy in stenocardia patients].[莫西多明的新剂型、强力可伐汀和缓释可伐汀及其在心绞痛患者中的抗心绞痛疗效]

Ter Arkh. 1996;68(1):29-30.

9

Exercise-induced angina alleviated by intracoronary SIN-1.冠状动脉内注射SIN-1可缓解运动诱发的心绞痛。

Cardiology. 1987;74(6):427-35. doi: 10.1159/000174235.

10

Efficacy and safety of molsidomine once-a-day in patients with stable angina pectoris.单硝酸异山梨酯每日一次给药治疗稳定型心绞痛患者的疗效与安全性。

Int J Cardiol. 2005 Jan;98(1):79-89. doi: 10.1016/j.ijcard.2004.01.007.

引用本文的文献

1

A pilot double-blind randomized placebo-controlled study of molsidomine 16 mg once-a-day in patients suffering from stable angina pectoris: correlation between efficacy and over time plasma concentrations.一项针对稳定型心绞痛患者每日一次服用16毫克莫西多明的双盲随机安慰剂对照试验研究：疗效与血浆浓度随时间的相关性。

Eur J Clin Pharmacol. 2003 Jul;59(3):227-32. doi: 10.1007/s00228-003-0597-z. Epub 2003 May 7.

2

How to standardize vasomotor tone in serial studies based on quantitation of coronary dimensions?

Int J Card Imaging. 1998 Dec;14(6):357-72. doi: 10.1023/a:1006076409185.